Perspective Therapeutics, Inc. (CATX) News
Track canonical SquawkNews coverage tagged to CATX, Perspective Therapeutics, Inc.. This hub brings together deduplicated headlines about alpaca us equities, markets catalysts, earnings, analyst actions, and wider market events so traders can review how a developing story changed over time. It contains 3 indexed stories across 3 publication days and is ordered by the same first-publication timeline used by LiveCast.
L
Perspective Therapeutics shares are trading higher after the company reported better-than-expected Q2 EPS results.
Perspective Therapeutics shares are trading higher after the company reported better-than-expected Q2 EPS results.
EARNINGS | Aug 11, 2026, 07:53 PM UTC
L
CATX - Perspective Therapeutics to Provide Business Highlights and Report Second Quarter 2026 Financial Results
CATX - Perspective Therapeutics to Provide Business Highlights and Report Second Quarter 2026 Financial Results
EARNINGS | Jul 31, 2026, 10:30 AM UTC
L
CATX - Perspective Therapeutics Receives European Orphan Medicinal Product Designation for [212Pb]VMT-α-NET in GEP-NETs
CATX - Perspective Therapeutics Receives European Orphan Medicinal Product Designation for [212Pb]VMT-α-NET in GEP-NETs
EQUITY | Jul 28, 2026, 10:30 AM UTC